Mymetics Corp (MYMX)

[Work Harder]

(PFÄFFIKON / SEATTLE), June 16, 2020

Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine.

AGC Biologics will manufacture SARS-CoV-2 vaccine for partner Saiba AG.

The company currently employs more than 1000 employees worldwide. AGC Biologics’ global network spans three continents, with cGMP-compliant facilities in Seattle, Washington; Boulder, Colorado; Copenhagen, Denmark; Heidelberg, Germany; and Chiba, Japan.

https://saiba-biotech.com/Latest

LOL

Look who is across the street

https://www.google.com/maps/place/AGC+Biologics/@55.7349625,12.4789216,17z/data=!4m5!3m4!1s0x0:0x3291174bcd8a0e13!8m2!3d55.7351528!4d12.478471

Where is the Graffiti

https://www.google.com/maps/place/AGC+Biologics/@47.8030575,-122.2028746,17z/data=!4m5!3m4!1s0x54900f96073a5a17:0x650cf6f739d425ff!8m2!3d47.802908!4d-122.200804

ROTFLOL

AGC Biologics' $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint

https://www.prnewswire.com/news-releases/agc-biologics-18m-investment-in-seattle-and-denmark-facilities-strengthens-global-footprint-300954972.html